ActiGraph Partners with VivoSense
ActiGraph, the provider of medical-grade wearable activity and sleep monitoring solutions, has announced a new partnership with data analytics specialist VivoSense. The partnership will allow both companies to deliver sponsor access to secure, regulated, analyzed, and contextualized sensor data from patients participating in pharmaceutical clinical trials. VivoSense is a regulatory compliant, cloud based platform for the analysis of wearable sensor data. VivoSense with VivoCapture provides pharmaceutical sponsors with access to contextualized sensor data, metadata, analyzed, and raw signals. The platform makes use of Azure authentication and authorization, computing, and storage in a regulated sensor data warehouse.
ActiGraph’s wearable activity monitoring sensors provide pharma companies with levels of continuous, high-resolution physiologic data. The collection and accurate analysis of biometric data streams is vital in today’s clinical research and helps to accelerate study enrollment and patient engagement.
VivoSense analyzes data from any biometric sensor or combination of sensors to integrate, clean, analyze, and derive new biomarkers. The large physiological data-sets generated by these sensors help to monitor health and understand the effects of new medicines and therapies in development.
"Providing context to collected wearable sensor data empowers our clients to make better sense of the data and investigate novel disease endpoints,” said Dudley Tabakin, CEO and Co-founder of VivoSense. "Combining ActiGraph’s world-leading activity and sleep monitoring with other physiological measures, cleaned and analyzed by VivoSense, will provide context to all clinical trials measures."
For more information, visit www.actigraphcorp.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
